Africa’s largest-ever vaccination drive is well underway.52 African countries are rolling out COVID-19 vaccines and over 73 million doses have been administered on the continent.
With WHO support, Botswana is one of four African countries that have completed an intra action review of their early COVID-19 vaccine rollout to help shape the next phase.
“The aim was to spot challenges and best practices so we can keep customising our rollout. It helped us take quick corrective measures and improve our services,” says Dr Malebogo Kebabonye, Director of Health Services at Botswana’s Ministry of Health and Wellness.
Rigorous planning
Botswana’s National Vaccine Deployment Plan was ready a month before the first vaccines arrived in late March. The country conducted surveys to gauge public perceptions around vaccinations and set up a national ‘ArmReady’ information campaign to prepare the public.
“Our national deployment plan was sanctioned at the level of the Cabinet Office. The surveys showed 76% acceptance of the vaccination among the public. Through the ‘ArmReady’ campaign, we also sought to pre-empt small pockets of resistance,” says Dr Kebabonye.
“Our first phase, aiming to reach 264 000, is about protecting the health system. The second is to ensure continued economic activity. The final phase will target 18-29 year olds.”
Botswana had received 473 000 doses of the AstraZeneca-Covishield, Pfizer and Sinovac vaccines by early July and by then had given first doses to 150 000 people, around one tenth of the country’s adult population. This included 70% of all health workers and 60% of people aged over 55.
“Multi sectoral involvement and coordination from the Presidential Task Force and the Ministry of Health were key. We appointed liaison offices at the national and sub-national levels and used community centres as vaccination sites. This helped communities to take ownership,” Dr Kebabonye explains.
“We piloted our rollout at a number of sites first, and then grew them out based on the capacity we had. Given the supply issues, this snowballing approach has been very handy.”
Covering all bases
Crucially, Botswana planned for a range of scenarios and challenges before the rollout began, including uncertainty around the supply of vaccines.
“We’re really urging African countries to plan for multiple scenarios, just like Botswana did,” says Chanda Chikwanda, who leads WHO Africa’s Vaccines Learning Agenda, which helps share lessons between African countries to strengthen the rollout of vaccines.
“We need to be flexible, depending on how the vaccine responses are going and on whether vaccines arrive on time. There are so many possible scenarios, so flexibility is imperative.”
Good financing, including resource mobilization, as well as constant monitoring and evaluation tools based on good data collection all strengthened Botswana’s early rollout.
“Countries that put an emphasis on resource mobilization have shown themselves to be best placed to do well. Eswatini secured enough funds to vaccinate its entire population and Rwanda, Angola and Ghana all invested in cold chain capacities early,” says Chikwanda.
“We must also get to the hard-to-reach groups, including mobile populations and people living in faraway areas. Lesotho used the flying doctors to reach remote communities.”
Challenges
According to Dr Kebabonye, the squeeze on supplies of vaccines has also served to push up public distrust in Botswana’s vaccine rollout.
A level of vaccine hesitancy was also found among some younger health workers, which was compounded by the spread of misinformation on and offline.
Like many countries, Botswana has faced challenges in ensuring enough vaccinators, nurses and health professionals and support staff are on hand.
Equipment shortages and low internet bandwidth in some areas has hampered the use of the electronic data systems that track the administration of vaccines and adverse effects.
“We’ve expanded the knowledge we share with our healthcare workers and communities around [any potential] adverse effects, including on assessing and managing side effects,” says Dr Kebabonye.
Constant learning
When asked for advice for other African countries, Dr Kebabonye cites an incremental and agile approach, with a strong emphasis on consistent testing and learning.
“These reviews, like the one we ran in April with WHO, need to be continuous processes that all countries do to keep on improving,” said Dr Kebabonye.
Nine more African countries recently expressed interest in conducting similar reviews.
“We’re learning as we go to some extent with this new virus and unprecedented vaccination drive,” said Dr Phionah Atuhebwe, New Vaccines Introduction Officer with the World Health Organization’s (WHO) Africa Regional Office.
“It is crucial that we keep a close, sharp eye on progress and that we share lessons between countries. This way we all improve our COVID-19 vaccine rollout together.”
Distributed by APO Group on behalf of WHO Regional Office for Africa.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
